Atlas Trials

A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough

Clinical trial NCT06213363 · UNKNOWN

Trial details

NCT number
NCT06213363
Sponsor
Beijing Tide Pharmaceutical Co., Ltd
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Chronic Cough
Start date
2024-02-01
Primary completion
2024-10-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.